Crow, based on some recent posts on the TCL board by dssu6255 and others I think CDEX needs to get that cheaper unit out sooner than later. There's only so many hospitals that can be skimmed for top dollar before the sales price needs to be corrected to start targeting more of the market.
Offering a 38% discount is a start, but apparently it's still not low enough for the smaller hospitals.
If you take away all the hospitals that were paid or otherwise compensated partners, I wonder how many Valimeds have been sold at full asking price.
Breakeven is still a long way in the distance IMO.
In the mean time, CDEX continues to sell their most successful product to finance a 20 miilion dollar development that should have cost a fraction of that amount.
That's exactly why institutions do not invest in the penny stock market. Unreal.
News 
Market Data 
Discover 
AI
